NEW YORK (GenomeWeb) – Genomic Health announced today that it expects preliminary revenue for the year ended December 31, 2015, to be between $285 million and $286 million, an approximate 4 percent increase over 2014's $275.7 million, but slightly below the company's 2015 guidance and below analysts' estimates for the year, which averaged $291.6 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.